Molecular Diagnostics

When the coronavirus 2019 (COVID-2019) outbreak, 3DMed responded rapidly by developing a series of RT-qPCR-based tests (the ANDiS SARS-CoV-2 Detection Kit and the ANDiS SARS-CoV-2 & Influenza A/B Detection Kit) for qualitative detection of SARS-CoV-2 RNA in upper and lower respiratory specimens collected from individuals who meet the CDC criteria for SARS-CoV-2 testing.

Based on the advantage of PNA material and accumulated knowledge, Panagene have developed various innovative platform technologies on molecular diagnostics covering multiplexing, mutated gene specific amplification, SNP discrimination and so on. To meet rapidly changing diagnostic market needs.

PANAGENE has expertise especially in cancer-related molecular diagnostics including companion diagnostics using tissue or liquid biopsy specimens. Panagene advanced technology provides not only high level of detection but also simple and convenient procedure to be used easily in the front-line hospitals and clinical laboratories by themselves.